Lovastatin Therapy in Rheumatoid Arthritis (ARA02)

Cynthia Aranow & Betty Diamond
Eighty adults will be enrolled in this study to evaluate lovastatin therapy in Rheumatoid Arthritis. Participants will receive 80 mg lovastatin po qd or 80 mg placebo po qd for twelve weeks.
This data repository is not currently reporting usage information. For information on how your repository can submit usage information, please see our documentation.